---
title: "Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293973563.md"
description: "Regeneron Pharmaceuticals Inc. (REGN) shares rose 1.70% to $667.17, outperforming peers like Amgen and Gilead on a strong trading day. This marks the third consecutive daily gain for REGN, though it remains 18.75% below its 52-week high. The broader market also saw gains, with the S&P 500 up 0.02% and the Dow Jones Industrial Average rising 0.51%. Trading volume was below the 50-day average."
datetime: "2026-07-27T20:46:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293973563.md)
  - [en](https://longbridge.com/en/news/293973563.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293973563.md)
generator: "portal-rs"
---

# Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) rallied 1.70% to $667.17 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,413.18 and the Dow Jones Industrial Average rising 0.51% to 52,210.08.

This was the stock's third consecutive day of gains.

Regeneron Pharmaceuticals Inc. closed 18.75% below its 52-week high of $821.11, which the company reached on January 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Amgen Inc. (AMGN) rose 0.06% to $376.26, Moderna Inc. (MRNA) rose 2.89% to $55.63, and Gilead Sciences Inc. (GILD) rose 0.94% to $130.52.

Trading volume (649,983) remained 391,526 below its 50-day average volume of 1.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-27-26 1646ET

### Related Stocks

- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)

## Related News & Research

- [04:39 ETRegeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN](https://longbridge.com/en/news/296589805.md)
- [Regeneron Stock (REGN) Buckling as Shareholders Sue Over Cancer Drug Claims](https://longbridge.com/en/news/296616209.md)
- [Regeneron podcast turns science into immersive experience](https://longbridge.com/en/news/296758441.md)
- [Parallax Volatility Advisers L.P. Trims Holdings in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/297162579.md)
- [Wolfe Research Just Upgraded Moderna Stock. Here's Why.](https://longbridge.com/en/news/296951590.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**